S
Surrozen D
D
SRZN
11.200
USD
-0.42
(-3.61%)
مغلق
حجم التداول
174
الربح لكل سهم
-11
العائد الربحي
-
P/E
-1
حجم السوق
36,397,738
المقالات
العنوان: Surrozen
القطاع: Healthcare
الصناعة: Biotechnology
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).